background purpose coronary brachytherapy method prevent restenosis percutaneous transluminal coronary angioplasty ptca stent implantation outcome subject improvements physiological studies suggest target cells brachytherapy coronary arteries ptca hypoxic lack oxygen decreases effect low let linear energy transfer irradiation authors assumed reoxygenation hypoxic human coronary smooth muscle cells hcsmcs improves results coronary brachytherapy expression factor 1alpha gene rates growth apoptosis hypoxic reoxygenated hcsmcs analyzed material methods vitro model megacolonies hcsmcs developed exposure chronic hypoxia hcsmcs irradiated graded doses NUMBER NUMBER NUMBER NUMBER gy using 60co source hypoxia po2 NUMBER mmhg reoxygenation po2 approximately NUMBER mmhg reverse chain reaction analysis used quantify gene expression growth hcsmc megacolonies measured serially oxygen enhancement ratio oer calculated specific growth delay apoptosis hcsmcs quantified counting cells specific dna strand breaks using tunel assay results gene expression markedly suppressed reoxygenated cells versus hypoxic cells NUMBER min radiation doses NUMBER NUMBER vs NUMBER NUMBER p NUMBER apoptosis markedly increased reoxygenated hcsmcs oer NUMBER NUMBER ci confidence interval reoxygenated hcsmcs require NUMBER radiation dose achieve equivalent biological radiation effect compared hypoxic hcsmcs conclusion reoxygenation coronary smooth muscle cells considered option increase efficacy coronary brachytherapy used reduce radiation dose associated late effects catheter based beta gamma radiation evidence based hypoxia inducible hif 1alpha gamma irradiation rt pcr transcription polymerase hif 1alpha hif 1alpha gamma irradiation NUMBER NUMBER